Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this Issue
Drug safety advice
- Natalizumab (Tysabri): safety overview—progressive multifocal leukoencephalopathy, hypersensitivity, and hepatotoxicity
- Nicorandil: gastrointestinal ulceration
Yellow Card scheme update
- Promotion of the Scheme in community pharmacies
Hot topic
- Ezetimibe: new data from the ENHANCE trial
Stop Press
- Herbal products marketed for erectile dysfunction
Other information from the MHRA
- Patient Information Leaflet of the Month: Epipen
- Safe use of medical lasers and other optical radiation devices
- Oxygen cylinders and regulators: top tips leaflet
- MHRA challenges and priorities: response to public consultation
Drug Safety Update: Volume 1, Issue 11, June 2008 
